Atos supercomputers support global coronavirus research in Brazil

Belonging to Laboratório Nacional de Computação Científica and SENAI CIMATEC, the higher-effectiveness pcs Santos Dumont and Ogbon, the two produced by Atos, are currently being utilized on research for the advancement of medicines and vaccines versus COVID-19

 

Brazil, 27 April 2020

Atos, a world wide leader in electronic transformation, announces that two of its supercomputers in Brazil are currently being utilized in investigate for the advancement of vaccines and drugs versus the coronavirus. These are Santos Dumont, which belongs to the National Laboratory for Scientific Computing (LNCC), and Ogbon, at SENAI CIMATEC. The supercomputers are viewed as the major in Brazil and in South America and are in the Major five hundred listing of the most powerful supercomputers in the environment. The initiative is led by the Chemistry Office at Stanford College, in the United States.

The intention is to contribute to the Folding@home project, coordinated by the College, which research the evolution of the coronavirus in the human human body, primarily based on the interaction of viral proteins, which opens the way for the advancement of certain vaccines and drugs. Owing to their higher effectiveness and capability, the two supercomputers are ideally positioned to contribute to this style of investigate. They can be utilized for parallel processing, intricate calculations and intensive and intense duties – processes that desire quadrillions of calculations for each second.

Santos Dumont, installed at LNCC, in Rio de Janeiro, aims to have sixty% of its capability committed to the Folding@home project, which is 2 petaflops (equal to the computational capability of 2 million laptops performing together). Ogbon, situated at the SENAI CIMATEC Supercomputing Middle, in Salvador, aims to have 50% of its capability devoted to investigate, which corresponds to one petaflops (or one million laptops).

“Our intent is to join people, technology and corporations to enable increase the environment in which we dwell. The use of our supercomputers in the fight versus Covid-19’s advancement is specifically this. We are pretty proud to offer higher-effectiveness technology to help and develop investigate that can conserve millions of lives”, claims Luis Casuscelli, Director of Significant Data and Cybersecurity at Atos in South America. “Atos machines have currently supported LNCC scientists to discover the supply of the virus’s entry, and to discover that each and every unique supply has a unique attribute –which will help scientists and scientists build much more helpful vaccines.”

***

About Atos

Atos is a world wide leader in electronic transformation with above one hundred ten,000 staff in 73 nations around the world and once-a-year income of above € 11 billion. European amount one in Cloud, Cybersecurity and Higher-General performance Computing, the Team delivers close-to-close Orchestrated Hybrid Cloud, Significant Data, Company Applications and Electronic Office alternatives. The team is the All over the world Information and facts Technological know-how Spouse for the Olympic & Paralympic Game titles and operates under the brands Atos, Atos Syntel, and Unify. Atos is a SE (Societas Europaea), detailed on the CAC40 Paris stock index.

The intent of Atos is to enable structure the long run of the facts technology area. Its skills and products and services help the advancement of knowledge, training as very well as multicultural and pluralistic strategies to investigate that contribute to scientific and technological excellence. Across the environment, the team allows its customers, staff and collaborators, and users of societies at significant to dwell, work and develop sustainably and confidently in the facts technology area.

Push get in touch with:

Laura Fau | [email protected] | +33 6 73 64 04 18 | @laurajanefau